DK14887A - Fast farmaceutisk praepatet med langvarig afgivelse af det aktive stof - Google Patents

Fast farmaceutisk praepatet med langvarig afgivelse af det aktive stof

Info

Publication number
DK14887A
DK14887A DK014887A DK14887A DK14887A DK 14887 A DK14887 A DK 14887A DK 014887 A DK014887 A DK 014887A DK 14887 A DK14887 A DK 14887A DK 14887 A DK14887 A DK 14887A
Authority
DK
Denmark
Prior art keywords
long
active substance
pharmaceutical preparation
term delivery
fixed pharmaceutical
Prior art date
Application number
DK014887A
Other languages
English (en)
Other versions
DK175215B1 (da
DK14887D0 (da
Inventor
Mahendra Govind Pankhania
Colin David Melia
John Francis Lampard
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of DK14887D0 publication Critical patent/DK14887D0/da
Publication of DK14887A publication Critical patent/DK14887A/da
Application granted granted Critical
Publication of DK175215B1 publication Critical patent/DK175215B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK198700148A 1986-01-18 1987-01-13 Fast farmaceutisk præparat med langvarig afgivelse af det aktive stof samt fremgangsmåde til fremstilling deraf DK175215B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8601204 1986-01-18
GB868601204A GB8601204D0 (en) 1986-01-18 1986-01-18 Therapeutic agents

Publications (3)

Publication Number Publication Date
DK14887D0 DK14887D0 (da) 1987-01-13
DK14887A true DK14887A (da) 1987-07-19
DK175215B1 DK175215B1 (da) 2004-07-12

Family

ID=10591589

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198700148A DK175215B1 (da) 1986-01-18 1987-01-13 Fast farmaceutisk præparat med langvarig afgivelse af det aktive stof samt fremgangsmåde til fremstilling deraf

Country Status (23)

Country Link
US (1) US5415871A (da)
EP (1) EP0234670B1 (da)
JP (1) JPH0669965B2 (da)
KR (1) KR940011242B1 (da)
AT (1) ATE77548T1 (da)
AU (2) AU608208B2 (da)
CA (1) CA1313133C (da)
DE (1) DE3779933T2 (da)
DK (1) DK175215B1 (da)
ES (1) ES2042541T4 (da)
FI (1) FI93608C (da)
GB (1) GB8601204D0 (da)
GR (1) GR3005796T3 (da)
IE (1) IE59333B1 (da)
IL (1) IL81281A (da)
IN (1) IN164250B (da)
MX (1) MX4949A (da)
MY (1) MY100721A (da)
NO (1) NO173317C (da)
NZ (1) NZ218907A (da)
PH (1) PH26408A (da)
PT (1) PT84133B (da)
ZA (1) ZA87173B (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464067A (en) * 1994-01-11 1995-11-07 Dulak; Joseph O. Golf marker cleaner and grass remover

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1191674B (it) * 1986-03-07 1988-03-23 Eurand Spa Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
IT1250483B (it) * 1990-08-30 1995-04-07 Eurand Int Sistema di ritardo a matrice multipla
DE4140184C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140192C2 (de) * 1991-12-05 1996-02-29 Alfatec Pharma Gmbh Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140172C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Ibuprofen enthaltendes Arzneimittel
DE4140179C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Ibuprofen enthaltendes Arzneimittel
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5292534A (en) * 1992-03-25 1994-03-08 Valentine Enterprises, Inc. Sustained release composition and method utilizing xanthan gum and an active ingredient
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
JP2628231B2 (ja) * 1992-12-30 1997-07-09 エフ エム シー コーポレーション 放出調整賦形剤として容易に入手できるコンニャクグルコマンナン
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US6726930B1 (en) * 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5662933A (en) 1993-09-09 1997-09-02 Edward Mendell Co., Inc. Controlled release formulation (albuterol)
US6395303B1 (en) * 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
FR2729857B1 (fr) 1995-01-27 1997-04-04 Rhone Poulenc Chimie Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire
WO1997026865A1 (en) * 1996-01-29 1997-07-31 Edward Mendell Co., Inc. Sustained release excipient
AU695734B2 (en) 1996-07-08 1998-08-20 Penwest Pharmaceuticals Co. Sustained release matrix for high-dose insoluble drugs
IN186245B (da) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6607751B1 (en) * 1997-10-10 2003-08-19 Intellipharamaceutics Corp. Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US20030153623A1 (en) * 1998-07-22 2003-08-14 Yamanouchi Pharmaceutical Co., Ltd. Solid preparation containing sparingly soluble NSAIDs
GB9816723D0 (en) * 1998-08-01 1998-09-30 Boots Co Plc Therapeutic agents
WO2000033818A1 (en) 1998-12-11 2000-06-15 Nostrum Pharmaceuticals, Inc. Sustained release tablet containing hydrocolloid and cellulose ether
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
WO2001022940A1 (en) * 1999-09-30 2001-04-05 Edward Mendell Co., Inc. Sustained release matrix systems for highly soluble drugs
US7235258B1 (en) * 1999-10-19 2007-06-26 Nps Pharmaceuticals, Inc. Sustained-release formulations for treating CNS-mediated disorders
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
AR030941A1 (es) * 2000-08-22 2003-09-03 Agres Ltd Composicion liberable y metodo de preparacion
WO2002015702A1 (en) * 2000-08-22 2002-02-28 Agresearch Limited A thermo-stable bio-matrix
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1330236A2 (en) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
WO2002041876A1 (en) * 2000-11-22 2002-05-30 Lupin Limited Pharmaceutical composition for controlled release of an active ingredient
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030072731A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing starch or dextrin
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US8329216B2 (en) * 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
CA2452871C (en) * 2001-07-06 2011-10-04 Endo Pharmaceuticals, Inc. Oxymorphone controlled release formulations
US6705028B2 (en) * 2001-09-12 2004-03-16 Honda Giken Kogyo Kabushiki Kaisha Self-propelled snowplow vehicle
US20030091635A1 (en) * 2001-09-26 2003-05-15 Baichwal Anand R. Opioid formulations having reduced potential for abuse
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
WO2003043607A1 (en) * 2001-11-19 2003-05-30 Lupin Limited A pharmaceutical composition for controlled release of a beta-lactam antibiotic
KR20050009983A (ko) * 2002-03-22 2005-01-26 시락 아게 트라마돌의 서방성 제제
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
BR0317177A (pt) * 2002-12-13 2005-10-25 Cilag Ag Preparações de liberação controlada compreendendo tramadol e topiramato
WO2004058152A2 (en) * 2002-12-16 2004-07-15 Ranbaxy Pharmaceuticals Inc. An extended release pharmaceutical composition of phenytoin sodium
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
WO2004112756A1 (en) * 2003-06-26 2004-12-29 Isa Odidi Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
AU2004311577A1 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
DE60319982T2 (de) * 2003-09-01 2009-04-16 Jpm - The Jordanian Pharmaceutical Manufacturing Co. Ltd. Universelle Zusammensetzung zur kontrollierten Wirkstofffreigabe enthaltend Xanthangummi und Natriumalginat
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
ES2244324B1 (es) * 2004-03-25 2006-11-16 Ferrer Internacional, S.A. Composiciones diureticas de liberacion prolongada.
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
US20050252144A1 (en) * 2004-04-29 2005-11-17 Macdonald Robert A Veneers for walls, retaining walls and the like
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
BRPI0514303A (pt) * 2004-08-11 2008-06-10 Myriad Genetics Inc composição farmacêutica e método para tratar distúrbios neurodegenerativos
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
CA2578224A1 (en) * 2004-08-25 2006-03-09 Essentialis, Inc. Pharmaceutical formulations of potassium atp channel openers and uses thereof
US20070077297A1 (en) * 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
CA2584469A1 (en) * 2004-10-26 2006-05-04 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
EP1909770B1 (en) * 2005-02-22 2013-03-20 Sun Pharmaceutical Industries Limited Oral controlled release composition containing levetiracetam
US9757384B2 (en) 2005-04-06 2017-09-12 Essentialis, Inc. Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
CA2615063A1 (en) * 2005-07-22 2007-02-01 Myriad Genetics, Inc. High drug load formulations and dosage forms
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
WO2007069874A1 (en) * 2005-12-16 2007-06-21 Hanmi Pharm. Co., Ltd. Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
AU2006335153B2 (en) 2006-01-05 2012-03-15 Essentialis, Inc. Salts of potassium ATP channel openers and uses thereof
US8309104B2 (en) * 2006-03-02 2012-11-13 Watson Pharmaceuticals, Inc. Oral controlled release formulation for sedative and hypnotic agents
US20070212414A1 (en) * 2006-03-08 2007-09-13 Penwest Pharmaceuticals Co. Ethanol-resistant sustained release formulations
US9561188B2 (en) * 2006-04-03 2017-02-07 Intellipharmaceutics Corporation Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
US20080033045A1 (en) * 2006-07-07 2008-02-07 Myriad Genetics, Incorporated Treatment of psychiatric disorders
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
US20080318994A1 (en) 2007-06-21 2008-12-25 Endo Pharmaceuticals, Inc. Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
US20090124650A1 (en) * 2007-06-21 2009-05-14 Endo Pharmaceuticals, Inc. Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instructions on Effects of Alcohol
US20080318993A1 (en) * 2007-06-21 2008-12-25 Endo Pharmaceuticals, Inc. Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Hepatic Impairment
JP2010532383A (ja) * 2007-07-02 2010-10-07 エッセンシャリス，インク． カリウムａｔｐチャネル開口薬の塩およびその使用
DE102007032662A1 (de) * 2007-07-13 2009-01-22 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen enthaltend ein oder mehrere Apiogalacturonane oder einen oder mehrere Apiogalacturonane enthaltenden Extrakt aus Zostera marina und einen zusätzlichen Gehalt an einem oder mehreren Hydrokolloiden
TW201200165A (en) * 2010-02-22 2012-01-01 Daiichi Sankyo Co Ltd Oral solid extended release dosage form
EP2793853B1 (en) * 2011-12-23 2015-12-16 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical formulations of flurbiprofen and glucosamin
WO2013100881A2 (en) 2011-12-27 2013-07-04 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Combined pharmaceutical formulation containing diacerein
WO2013130411A1 (en) 2012-02-27 2013-09-06 Essentialis, Inc. Salts of potassium atp channel openers and uses thereof
WO2014007777A1 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Combined capsule formulations of nsaids
WO2014007778A1 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi COMBINED IMMEDIATE RELEASE FORMULATIONS OF NSAIDs
WO2016077629A1 (en) 2014-11-14 2016-05-19 Essentialis, Inc. Methods for treating subjects with prader-willi syndrome or smith-magenis syndrome
CN108904451A (zh) * 2018-07-27 2018-11-30 广州柏赛罗药业有限公司 缓释制剂

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR901111A (fr) * 1943-08-31 1945-07-18 Perfectionnement aux dispositifs de réglage de terrage des charruesbascules
US3065143A (en) 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
FR2138492A1 (en) * 1971-05-27 1973-01-05 Cerm Cent Europ Rech Mauvernay Basic aluminium salts of gum xanthane - pharmaceutical gelling agents
DE2130545A1 (de) 1971-06-19 1972-12-21 Merck Patent Gmbh Pharmazeutischer Formkoerper
US4163777A (en) * 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
JPS5470420A (en) * 1977-11-10 1979-06-06 Sanei Kagaku Kogyo Kk Binder for medical tablet
US4248858A (en) 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
IN151913B (da) * 1980-01-11 1983-09-03 Boots Co Ltd
CA1207231A (en) * 1982-08-24 1986-07-08 Hans W. Zulliger Medicated suppository
US4717713A (en) * 1983-10-31 1988-01-05 Research Corporation Controlled release liquid pharmaceutical
JPS60219238A (ja) * 1984-04-14 1985-11-01 Hayashibara Biochem Lab Inc 徐崩性プルラン含有成形物とその製法
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8426152D0 (en) * 1984-10-16 1984-11-21 Reckitt & Colmann Prod Ltd Medicinal compositions
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
EP0182772A3 (fr) * 1984-11-22 1987-04-01 Benfar Compositions pharmaceutiques à libération prolongée, leur procédé de préparation et leur utilisation
BE901111A (fr) * 1984-11-22 1985-03-15 Benfar Representee Par Vanderl Composition pharmaceutiques a liberation prolongee, leur procede de preparation et leur utilisation.
JPS61130239A (ja) * 1984-11-30 1986-06-18 Dai Ichi Seiyaku Co Ltd 複合体
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
IT1191674B (it) * 1986-03-07 1988-03-23 Eurand Spa Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464067A (en) * 1994-01-11 1995-11-07 Dulak; Joseph O. Golf marker cleaner and grass remover

Also Published As

Publication number Publication date
IL81281A (en) 1990-11-29
GR3005796T3 (da) 1993-06-07
DK175215B1 (da) 2004-07-12
IL81281A0 (en) 1987-08-31
FI93608C (fi) 1995-05-10
GB8601204D0 (en) 1986-02-19
US5415871A (en) 1995-05-16
EP0234670A3 (en) 1988-01-13
CA1313133C (en) 1993-01-26
MY100721A (en) 1991-01-31
EP0234670A2 (en) 1987-09-02
AU608208B2 (en) 1991-03-28
AU6762587A (en) 1987-07-23
AU628754B2 (en) 1992-09-17
ATE77548T1 (de) 1992-07-15
NO870181D0 (no) 1987-01-16
DE3779933D1 (de) 1992-07-30
NO870181L (no) 1987-07-20
JPS62181227A (ja) 1987-08-08
AU7946291A (en) 1991-09-12
MX4949A (es) 1993-12-01
FI93608B (fi) 1995-01-31
PH26408A (en) 1992-07-02
ZA87173B (en) 1987-08-26
NZ218907A (en) 1989-05-29
EP0234670B1 (en) 1992-06-24
JPH0669965B2 (ja) 1994-09-07
IN164250B (da) 1989-02-04
PT84133B (pt) 1989-05-31
ES2042541T4 (es) 1996-07-16
IE59333B1 (en) 1994-02-09
PT84133A (en) 1987-02-01
DK14887D0 (da) 1987-01-13
DE3779933T2 (de) 1992-12-10
NO173317C (no) 1993-12-01
FI870155A0 (fi) 1987-01-15
IE863420L (en) 1987-07-18
FI870155A (fi) 1987-07-19
KR870006896A (ko) 1987-08-13
KR940011242B1 (ko) 1994-12-03
ES2042541T3 (es) 1993-12-16
NO173317B (no) 1993-08-23

Similar Documents

Publication Publication Date Title
DK14887D0 (da) Fast farmaceutisk praepatet med langvarig afgivelse af det aktive stof
NO175763C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat hvor DL-tryptofan, eventuelt i kombinasjon med fumarsyre, anvendes som hjelpestoffer
DE3679722D1 (de) Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung.
ES2055904T3 (es) Composiciones para suministro de farmacos.
GB8613811D0 (en) Composition &amp; method
PT615754E (pt) Formas solidas de administracao oral de libertacao controlada flupertina
ATE179602T1 (de) Stabilisierte, feste pharmazeutische zubereitung, die dextromethorphan phenylpropanolamine und coffein enthält
LV10954A (lv) Benzimidazola atvasinajumi to iegusanas panemiens un tos saturosa farmaceitiska kompozicija
ES2051709T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica para uso parenteral que contiene calcitonina como el ingrediente activo.
ZA91115B (en) Topical compositions
ATE110564T1 (de) Pharmazeutische zusammensetzungen mit verzögerter freisetzung zur oralen verabreichung sowie deren herstellungsverfahren.
ES2033512T3 (es) Composicion antiastenica, su procedimiento de preparacion y su utilizacion.

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK